Lv2
120 积分 2024-09-02 加入
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
12天前
已完结
Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets
17天前
已完结
Lecanemab in Early Alzheimer’s Disease
30天前
已完结
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
1个月前
已完结
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
1个月前
已关闭
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
1个月前
已关闭
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy
1个月前
已完结
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B
1个月前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
1个月前
已完结
How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?
1个月前
已完结
皖公网安备34019202002308
